All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Although higher heart rate (HR) at baseline has been associated with an increased risk of cardiovascular (CV) and all-cause mortality, the relationship of in-treatment HR over time to mortality in hypertensive patients with ECG left ventricular hypertrophy (LVH) has not been examined. METHODS AND RESULTS: Heart rate was evaluated over time in 9190 hypertensive patients treated with losartan- or atenolol-based regimens and followed with annual ECGs. During a mean follow-up of 4.8 ± 0.9 years, 814 patients (8.9%) died, 438 (4.8%) from CV causes. In univariate Cox analyses, every 10 bpm higher HR on in-treatment ECGs was associated with a 25% increased risk of CV death [95% confidence interval (CI): 14-32%] and a 27% greater risk of all-cause mortality (95% CI: 21-34%). In an alternative analysis, persistence or development of a HR ≥ 84 bpm (upper quintile of baseline HR) was associated with an 89% greater risk of CV death (95% CI: 49-141%) and a 97% increased risk of all-cause mortality (95% CI: 65-135%). After adjusting for treatment with losartan vs. atenolol, baseline risk factors for death, baseline HR, baseline and in-treatment systolic and diastolic pressure, incident myocardial infarction, and the known predictive value of baseline and in-treatment QRS duration and ECG LVH, higher in-treatment HR in time-varying multivariable Cox models remained strongly predictive of mortality: every 10 bpm higher HR was associated with a 16% increased adjusted risk of CV mortality (95% CI: 6-27%) and a 25% greater risk of all-cause mortality (95% CI: 17-33%), with persistence or development of a HR ≥ 84 associated with a 55% greater risk of CV death (95% CI: 16-105%) and a 79% greater adjusted risk of all-cause mortality (95% CI: 46-121%). CONCLUSION: Higher in-treatment HR on serial ECGs predicts greater likelihood of subsequent CV or all-cause mortality, independent of treatment modality, blood pressure lowering, regression of ECG LVH and changing QRS duration in hypertensive patients with ECG LVH. These findings support the value of serial assessment of HR for improved risk stratification in hypertensive patients. CLINICAL TRIALS REGISTRATION: http://clinicaltrials.gov/ct/show/NCT00338260?order=1cp.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Self-citationFox, K., Ford, I., Steg, P. G., Tendera, M., & Ferrari, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61170-8 · Cited by 1,099
Resting Heart Rate in Cardiovascular Disease
Fox, K., Borer, J. S., Camm, A. J., Danchin, N., Ferrari, R., Lopez Sendon, J. L., Steg, P. G., Tardif, J.-C., Tavazzi, L., & Tendera, M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.079 · Cited by 1,062
Okin, P. M. (2004) · JAMA · doi:10.1001/jama.292.19.2343 · Cited by 663
Self-citationJouven, X., Empana, J. P., Escolano, S., Buyck, J. F., Tafflet, M., Desnos, M., & Ducimetière, P. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.08.071 · Cited by 175 · cited 2×
“In middle aged, healthy working men followed for 20 years or more, the combination of a high resting HR and the highest tertile of change in HR between rest and year 5 of follow-up was associated with a modestly increased long-term all-cause mortality risk.(5) In patients with coronary artery disease and hypertension,…”
Background
Cited by
Resting Heart Rate: Risk Indicator and Emerging Risk Factor in Cardiovascular Disease
Böhm, M., Reil, J.-C., Deedwania, P., Kim, J. B., & Borer, J. S. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.09.016 · Cited by 236
Temporal changes in resting heart rate and deaths from ischemic heart disease
Nauman, J., Janszky, I., Vatten, L. J., & Wisløff, U. (2011) · JAMA · doi:10.1001/jama.2011.1826 · Cited by 181
“In studies of patient groups with cardiovascular disease, an increase in RHR has been associated with increased case fatality.(12,14,15) However, the association of longitudinal changes in RHR with the risk of ischemic heart disease (IHD) has not been assessed in population studies.”
BackgroundResultJulius, S., Palatini, P., Kjeldsen, S. E., Zanchetti, A., Weber, M. A., McInnes, G. T., Brunner, H. R., Mancia, G., Schork, M. A., Hua, T. A., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.10.025 · Cited by 179
Self-citationBöhm, M., Schumacher, H., Teo, K. K., Lonn, E. M., Mahfoud, F., Ukena, C., Mann, J. F. E., Mancia, G., Redon, J., Schmieder, R. E., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehy808 · Cited by 55
Dharod, A., Soliman, E. Z., Dawood, F., Chen, H., Shea, S., Nazarian, S., Bertoni, A. G., & for the MESA Investigators (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7655 · Cited by 45
Metadata
- Authors
- Okin, P. M., Kjeldsen, S. E., Julius, S., Hille, D. A., Dahlof, B., Edelman, J. M., & Devereux, R. B.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-07-02
- Volume
- 31
- Issue
- 18
- Pages
- 2271-2279
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2101476667
- Cited by
- 90
- References
- 5
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy. https://app.cochat.ai/papers/10.1093/eurheartj/ehq225
- The paper
- Okin, P. M., Kjeldsen, S. E., Julius, S., Hille, D. A., Dahlof, B., Edelman, J. M., & Devereux, R. B. (2010). All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy. European Heart Journal. https://doi.org/10.1093/eurheartj/ehq225
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.